Biomarker Technologies Market to 2027 - Global Analysis and Forecasts by Product (Consumables, Software and Services, Instruments), Technology (Immunoassay, Cytogenetic, Mass Spectrometry, NGS, PCR, Chromatography, Imaging Technologies, and Others), Application (Cancer, Infectious Disease, Autoimmune Diseases, Neurological, Cardiovascular Disorders, and Others), and Geography
- Advertising -
The biomarker technologies market is anticipated to grow in the forecast period owing to key factors such as increasing use of biomarkers for disease diagnostics, rising use of biomarkers for drug discovery coupled with high R&D expenditure, increasing life science research activities, increasing application areas of biomarkers and growing incidences of cancer and infectious diseases. However, technical issues related to sample collection and storage and risk of contamination hampers growth of this market.
North America is expected to contribute to the largest share in the biomarker technologies market in the forecast period, due to presence of large number of well-established market players in the U.S., increasing prevalence of cancer, cardiovascular diseases, neurological and autoimmune diseases, and growing aging population are likely to influence the growth of the biomarker technologies market. the growing investments in life science research is expected to boost the biomarker technologies market.
- Advertising -
However, Asia Pacific region is expected to be the fastest growing region owing to increasing prevalence of chronic diseases and growing focus on development of better diagnostic procedures.
The report analyzes factors affecting biomarker technologies market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biomarker technologies market in these regions.
The report also includes the profiles of key biomarker technologies companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
key players operating in the biomarker technologies market-
1. Agilent Technologies, Inc
2. Thermo Fisher Scientific Inc.
3. F. Hoffmann-La Roche Ltd.
4. Bio-Rad Laboratories, Inc.
6. Pacific Biomarkers
7. Nordic Bioscience
9. Illumina, Inc.
10. Hologic, Inc.
Report at bit.ly/2UynqxJ